Prolonged activated prothromboplastin time and breed specific variation in haemostatic analytes in healthy adult Bernese Mountain dogs

Veterinary Journal

Volumn 190, Issue 1, 2011, Pages 150-153

  Nikolic Nielsen, Lise ^a   Wiinberg, Bo ^a   Kjelgaard Hansen, Mads ^a   Jensen, Asger Lundorf ^a   Kristensen, Annemarie T ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

APTT; CLSI; PT; Reference interval; Thromboelastography

Indexed keywords

BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; D DIMER; FIBRINOGEN; VON WILLEBRAND FACTOR;

ADULT ANIMAL; ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; BLOOD ANALYSIS; BREED; CONTROLLED STUDY; DOG; FEMALE; HEMOSTASIS; MALE; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; THROMBOELASTOGRAPHY;

ANIMALS; BLOOD CHEMICAL ANALYSIS; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; DENMARK; DOGS; FEMALE; HEMOSTASIS; MALE; PROTHROMBIN; PROTHROMBIN TIME; REFERENCE VALUES; SPECIES SPECIFICITY; THROMBELASTOGRAPHY;

CANIS FAMILIARIS;

EID: 80053564116     PISSN: 10900233     EISSN: 15322971     Source Type: Journal    
DOI: 10.1016/j.tvjl.2010.09.016     Document Type: Article

References (24)

1. Arnold S., Müller A., Binder H., Meyers K., Giger U. Von Willebrand factor concentrations in blood plasma of Bernese mountain dogs. Schweizer Archiv für Tierheilkunde 1997, 139:177-182.
2. Bowbrick V.A., Mikhailidis D.P., Stansby G. The use of citrated whole blood in thromboelastography. Anesthesia and Analgesia 2000, 90:1086-1088.
3. Chinn D.R., Dodds W.J., Selcer B.A. Prekallikrein deficiency in a dog. Journal of American Veterinary Medical Association 1986, 188:69-71.
4. Chng W.J., Sum C., Kuperan P. Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital. Singapore Medical Journal 2005, 46:450-456.
5. Francois D., Trigui N., Leterreux G., Flaujac C., Horellou M.H., Mazaux L., Vignon D., Conard J., de Mazancourtde P. Severe prekallikrein deficiencies due to homozygous C529Y mutations. Blood Coagulation and Fibrinolysis 2007, 18:283-286.
6. Geffre A., Friedrichs K., Harr K., Concordet D., Trumel C., Braun J.P. Reference values: a review. Veterinary Clinical Pathology 2009, 38:288-298.
7. Kitchen S. Problems in laboratory monitoring of heparin dosage. British Journal of Haematology 2000, 111:397-406.
8. Kjelgaard-Hansen M. Stay afloat in the tsunami: a focus on clinical relevance when partitioning RIs. The Veterinary Journal 2010, 185:245-246.
9. Kraus K.H., Johnson G.S. Von Willebrand's disease in dogs. Current Veterinary Therapy X 1989, 822. W.B. Saunders Co., Philadelphia. R.W. Kirk (Ed.).
10. LaDuca F.M., Tourbaf K.D. Fletcher factor deficiency, source of variations of the activated partial thromboplastin time test. American Journal of Clinical Pathology 1981, 75:626-628.
11. Lisciandro G.R., Brooks M., Catalfamo J.L. Contact factor deficiency in a German shorthaired pointer without clinical evidence of coagulopathy. Journal of Veterinary Internal Medicine 2000, 14:308-310.
12. McIntyre J.A., Wagenknecht D.R., Faulk W.P. Antiphospholipid antibodies: discovery, definitions, detection and disease. Progress in Lipid Research 2003, 42:176-237.
13. Nielsen L., Kjelgaard-Hansen M., Jensen A.L., Kristensen A.T. Breed-specific variation of hematological and biochemical analytes in healthy Bernese Mountain dogs. Veterinary Clinical Pathology 2010, 10.1111/j.1939-165X.2009.00186.x.
14. Otto C.M., Dodds W.J., Greene C.E. Factor XII and partial prekallikrein deficiencies in a dog with recurrent gastrointestinal hemorrhage. Journal of American Veterinary Medical Association 1991, 198:129-131.
15. Papini R., Pellegrini O., Guidi G. Anticardiolipin antibodies in healthy and diseased dogs. Veterinary Record 2005, 156:732-734.
16. Pengo V., Tripodi A., Reber G., Rand J.H., Ortel T.L., Galli M., de Groot P.G. Update of the guidelines for lupus anticoagulant detection. Journal of Thrombosis and Haemostasis 2009, 7:1737-1740.
17. Rick, 2009. Coagulation testing. In: Young N.S., Gerson S.L., High K.A. (Eds.), Clinical Hematology, Mosby, pp. 100-120.
18. Stockham S.L., Scott M.A. Hemostasis. Fundamentals of Veterinary Clinical Pathology 2008, vol. 2:259-323. Blackwell Publishing Professional, Ames.
19. Stone M.S., Johnstone I.B., Brooks M., Bollinger T.K., Cotter S.M. Lupus-type " anticoagulant" in a dog with hemolysis and thrombosis. Journal of Veterinary Internal Medicine 1994, 8:57-61.
20. Vilar P., Couto C.G., Westendorf N., Iazbik C., Charske J., Marin L. Thromboelastographic tracings in retired racing greyhounds and in non-greyhound dogs. Journal of Veterinary Internal Medicine 2008, 22:374-379.
21. Wiinberg B., Jensen A.L., Kjelgaard-Hansen M., Rojkjaer R., Johansson P.I., Gade L.P., Gram D.X., Kristensen A.T. Study on biological variation of haemostatic parameters in clinically healthy dogs. Veterinary Journal 2007, 174:62-68.
22. Wiinberg B., Jensen A.L., Rojkjaer R., Johansson P., Kjelgaard-Hansen M., Kristensen A.T. Validation of human recombinant tissue factor-activated thromboelastography on citrated whole blood from clinically healthy dogs. Veterinary Clinical Pathology 2005, 34:389-393.
23. Wiinberg B., Jensen A.L., Rozanski E., Johansson P.I., Kjelgaard-Hansen M., Tranholm M., Kristensen A.T. Tissue factor activated thromboelastography correlates to clinical signs of bleeding in dogs. The Veterinary Journal 2009, 179:121-129.
24. Zondag A.C., Kolb A.M., Bax N.M. Normal values of coagulation in canine blood. Haemostasis 1985, 15:318-323.